ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.171,54
0,58%
S&P 500
5.487,03
0,25%
Dow Jones
38.834,86
0,15%
Euro vs US Dollar
1,07321
-0,14%
Bitcoin
66.282,52
2,02%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) News

TXG 10x Genomics Inc

19,77
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 13:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
10x Genomics Inc TXG NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 19,77 13:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
19,77
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.6.202422:08EDGAR2Form 8-K - Current report
06.6.202422:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31.5.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202422:05PRNUS10x Genomics Launches 5,000-Plex Gene Panel for Xenium
24.5.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.5.202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.5.202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.5.202422:27EDGAR2Form 144 - Report of proposed sale of securities
22.5.202422:23EDGAR2Form 144 - Report of proposed sale of securities
22.5.202422:17EDGAR2Form 144 - Report of proposed sale of securities
02.5.202422:05PRNUS10x Genomics to Present at the BofA Securities 2024..
30.4.202422:05PRNUS10x Genomics Reports First Quarter 2024 Financial Results
10.4.202422:05PRNUS10x Genomics to Report First Quarter 2024 Financial Results..
26.3.202414:00PRNUS10x Genomics Commercially Launches Visium HD Spatial Gene..
21.3.202421:05PRNUS10x Genomics Expands Xenium Menu with Multi-Modal Cell..
13.3.202421:05PRNUS10x Genomics Begins Commercial Shipments of Chromium GEM-X..
06.3.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:40EDGAR2Form 144 - Report of proposed sale of securities
26.2.202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202401:19EDGAR2Form 144 - Report of proposed sale of securities
23.2.202401:06EDGAR2Form 144 - Report of proposed sale of securities
23.2.202400:59EDGAR2Form 144 - Report of proposed sale of securities
20.2.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:05PRNUS10x Genomics to Present at the 44th Annual TD Cowen Health..
15.2.202423:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
15.2.202423:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15.2.202422:05EDGAR2Form 8-K - Current report
15.2.202422:05PRNUS10x Genomics Reports Fourth Quarter and Full Year 2023..
13.2.202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:05PRNUS10x Genomics Expands Leadership in Single Cell Analysis with..
05.2.202422:05PRNUS10x Genomics to Showcase New Cutting-Edge Technologies and..
24.1.202422:05PRNUS10x Genomics to Report Fourth Quarter and Full Year 2023..
18.1.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:08EDGAR2Form 144 - Report of proposed sale of securities
16.1.202422:07EDGAR2Form 8-K - Current report
08.1.202415:00EDGAR2Form 8-K - Current report
08.1.202415:00PRNUS10x Genomics Announces Preliminary Fourth Quarter and Full..
29.12.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:05PRNUS10x Genomics to Present at the 42nd Annual J.P. Morgan..
20.12.202322:05PRNUS10x Genomics Launches Xenium Catalyst Network
19.12.202315:00PRNUSIntegrative Study Conducted by 10x Genomics Combines Single..
18.12.202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202323:09EDGAR2Form 144 - Report of proposed sale of securities
13.12.202322:26PRNUSHigh Sensitivity and Specificity of the Xenium Platform from..
07.12.202315:00PRNUS10x Genomics and NIH CARD to Create Comprehensive Single..
28.11.202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
TXG
10x Genomics
USOTC
HYTLF
HyTerra (PK)
BIT
P20X37
NLBNPIT20X37 20240621 22
TG
A3LQJU
Cooperatieve Rabobank UA
BIT
P1RJD0
BNP Paribas Issuance
LSE
FEQD
Euqtyincgbpacc
NASDAQ
RSTRC
Rstar
ASX
MPGO
Many Peaks Gold
NASDAQ
SCMF
Southern Community Financial
USOTC
OTODF
Octodec Investments (PK)
COIN
CLIQBTC
Cliq
ASX
ANZSOM
USOTC
NRGOF
Pinnacle Silver and Gold (PK)
EU
C277S
C277S
TSX
PBH
Premium Brands
NASDAQ
AAXOMXX
JPMorgan Chase Financial...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten